The recommendation covers children with 5q SMA with a bi-allelic mutation in the SMN1 gene and a clinical diagnosis of SMA type 1; or patients with 5q SMA with a bi-allelic mutation in SMN1 and up ...
It has dramatic benefits when administered early, and Novartis has been working hard to encourage screening of newborns for the SMN1 gene mutation that causes SMA, in order to allow treatment to ...
A study based on a survey of 50 adults linked poorer quality sleep with more depressive symptoms and respiratory issues in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback